Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Flamion

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Nature Reviews. Drug Discovery|September 13, 2008
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemmaHans-Georg Eichler, Francesco Pignatti, Bruno Flamion, et al.
The Journal of Biological Chemistry|November 23, 2012
Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunctionBiswajit Chowdhury, Richard Hemming, Sabine Hombach-Klonisch, et al.
Diabetes|June 2, 2016
Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced DiabetesSophie Dogné, Géraldine Rath, François Jouret, et al.
Traffic (Copenhagen, Denmark)|February 8, 2014
Subcellular trafficking and activity of Hyal-1 and its processed forms in murine macrophagesEmeline Puissant, Florentine Gilis, Sophie Dogné, et al.
The Patient|November 11, 2020
Benefit-Risk or Risk-Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice ExperimentSebastian Heidenreich, Andrea Phillips-Beyer, Bruno Flamion, et al.
Pharmaceutical Medicine|February 1, 2024
Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical TrialsAndrea Phillips-Beyer, Ariane K Kawata, Leah Kleinman, et al.
Frontiers in Cell and Developmental Biology|August 21, 2024
Cascading renal injury after brain death: Unveiling glycocalyx alteration and the potential protective role of tacrolimusKaoutar Idouz, Asmae Belhaj, Benoit Rondelet, et al.
Biochemical and Biophysical Research Communications|July 12, 2011
Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidaseBenedicte Andre, Cecile Duterme, Kris Van Moer, et al.
Scientific Reports|June 17, 2022
Hyaluronidase 1 deficiency decreases bone mineral density in miceEmeline Puissant, Florentine Gilis, Virginie Tevel, et al.
International Journal of Molecular Medicine|June 21, 2006
Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injuryAnne-Emilie Declèves, Nathalie Caron, Denis Nonclercq, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Nature Reviews. Drug Discovery|September 13, 2008
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemmaHans-Georg Eichler, Francesco Pignatti, Bruno Flamion, et al.
The Journal of Biological Chemistry|November 23, 2012
Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunctionBiswajit Chowdhury, Richard Hemming, Sabine Hombach-Klonisch, et al.
Diabetes|June 2, 2016
Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced DiabetesSophie Dogné, Géraldine Rath, François Jouret, et al.
Traffic (Copenhagen, Denmark)|February 8, 2014
Subcellular trafficking and activity of Hyal-1 and its processed forms in murine macrophagesEmeline Puissant, Florentine Gilis, Sophie Dogné, et al.
The Patient|November 11, 2020
Benefit-Risk or Risk-Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice ExperimentSebastian Heidenreich, Andrea Phillips-Beyer, Bruno Flamion, et al.
Pharmaceutical Medicine|February 1, 2024
Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical TrialsAndrea Phillips-Beyer, Ariane K Kawata, Leah Kleinman, et al.
Frontiers in Cell and Developmental Biology|August 21, 2024
Cascading renal injury after brain death: Unveiling glycocalyx alteration and the potential protective role of tacrolimusKaoutar Idouz, Asmae Belhaj, Benoit Rondelet, et al.
Biochemical and Biophysical Research Communications|July 12, 2011
Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidaseBenedicte Andre, Cecile Duterme, Kris Van Moer, et al.
Scientific Reports|June 17, 2022
Hyaluronidase 1 deficiency decreases bone mineral density in miceEmeline Puissant, Florentine Gilis, Virginie Tevel, et al.
International Journal of Molecular Medicine|June 21, 2006
Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injuryAnne-Emilie Declèves, Nathalie Caron, Denis Nonclercq, et al.
Pageof 6